We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
576
PTC Therapeutics
PTCT
$5.51B
$550K 0.01%
+6,743
New +$487K
MMSI icon
577
Merit Medical Systems
MMSI
$5.16B
$550K 0.01%
7,928
+2,163
+38% +$143K
RRC icon
578
Range Resources
RRC
$9.62B
$536K 0.01%
14,400
+9,317
+183% +$378K
ANET icon
579
Arista Networks
ANET
$252B
$531K 0.01%
3,124
-109,777
-97% -$17.2M
EQNR icon
580
Equinor
EQNR
$106B
$525K 0.01%
16,732
-40,803
-71% -$1.52M
BHE icon
581
Benchmark Electronics
BHE
$2.79B
$525K 0.01%
+5,322
New +$425K
STT icon
582
State Street
STT
$53.1B
$524K 0.01%
3,092
+1,303
+73% +$201K
RL icon
583
Ralph Lauren
RL
$20.2B
$521K 0.01%
+1,298
New +$483K
GLXY
584
Galaxy Digital Inc
GLXY
$4.74B
$517K 0.01%
+18,901
New +$526K
CAR icon
585
Avis
CAR
$4.3B
$511K 0.01%
3,454
-7,539
-69% -$1.66M
SNEX icon
586
StoneX
SNEX
$8.49B
$507K 0.01%
6,416
-5,712
-47% -$429K
COIN icon
587
Coinbase
COIN
$46.2B
$504K 0.01%
+3,448
New +$622K
PEP icon
588
PepsiCo
PEP
$186B
$494K 0.01%
3,649
-30,988
-89% -$4.63M
SB icon
589
Safe Bulkers
SB
$867M
$493K 0.01%
78,074
-55,578
-42% -$371K
PFE icon
590
Pfizer
PFE
$158B
$489K 0.01%
20,295
+3,234
+19% +$84.6K
RGNX icon
591
Regenxbio
RGNX
$563M
$486K 0.01%
40,549
-1,603
-4% -$13.3K
EPAC icon
592
Enerpac Tool Group
EPAC
$1.8B
$485K 0.01%
+13,514
New +$474K
WBI
593
WaterBridge Infrastructure LLC
WBI
$1.79B
$480K 0.01%
+13,994
New +$407K
AVAH icon
594
Aveanna Healthcare
AVAH
$3.07B
$478K 0.01%
55,812
-72,981
-57% -$514K
LULU icon
595
lululemon athletica
LULU
$11B
$478K 0.01%
4,189
+2,831
+208% +$378K
CVI icon
596
CVR Energy
CVI
$4.99B
$476K 0.01%
17,268
-49,569
-74% -$1.57M
ENS icon
597
EnerSys
ENS
$6.47B
$473K 0.01%
+2,023
New +$439K
VNOM icon
598
Viper Energy
VNOM
$8.69B
$470K 0.01%
11,092
+6,207
+127% +$287K
ATKR icon
599
Atkore
ATKR
$3.18B
$469K 0.01%
6,163
-3,873
-39% -$292K
ABCL icon
600
AbCellera Biologics
ABCL
$3.53B
$466K 0.01%
59,396
-63,151
-52% -$309K
22 23
24
25 26

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.